Abstract
A selected set of new N 1- (6-fluoro-4-oxoquinolin-8-yl)amidrazone-3-carboxylates (8a_e) incorporating Npiperazines and related congeners has been synthesized by reacting the hydrazonoyl chloride, derived from 8-amino-6- fluoro-4-oxoquinloine-3-carboxylate, with the appropriate sec-cyclic amine. Their suggested structures are supported by elemental analysis, 1H NMR, 13C NMR and ESI-HRMS spectral data. These novel compounds (8a_e) were screened for their antitumor and antibacterial activity. While no significant antitumor activity was observed, compounds 8a, 8b and 8d have shown moderate in vitro antibacterial activity against Gram positive bacteria cells. Unlike the others, compound 8a has also shown to moderately inhibit the growth of Gram negative bacteria.
Keywords: N1-(4-Oxoquinolin-8-yl)hydrazonoyl chloride, nitrile imines, 1, 3-nucleophilic addition, amidrazones, antibacterial activity.
Graphical Abstract
Letters in Organic Chemistry
Title:Synthesis and Biological Activity of Some New N1-(6-fluoro-4-oxoquinolin- 8-yl)amidrazones
Volume: 11 Issue: 9
Author(s): Mohammed M. Abadleh, Mustafa M. El-Abadelah, Salim S. Sabri, Qasem M.A. Abdallah, Abdelrahman Nasr and Mohamed F. El-Badawy
Affiliation:
Keywords: N1-(4-Oxoquinolin-8-yl)hydrazonoyl chloride, nitrile imines, 1, 3-nucleophilic addition, amidrazones, antibacterial activity.
Abstract: A selected set of new N 1- (6-fluoro-4-oxoquinolin-8-yl)amidrazone-3-carboxylates (8a_e) incorporating Npiperazines and related congeners has been synthesized by reacting the hydrazonoyl chloride, derived from 8-amino-6- fluoro-4-oxoquinloine-3-carboxylate, with the appropriate sec-cyclic amine. Their suggested structures are supported by elemental analysis, 1H NMR, 13C NMR and ESI-HRMS spectral data. These novel compounds (8a_e) were screened for their antitumor and antibacterial activity. While no significant antitumor activity was observed, compounds 8a, 8b and 8d have shown moderate in vitro antibacterial activity against Gram positive bacteria cells. Unlike the others, compound 8a has also shown to moderately inhibit the growth of Gram negative bacteria.
Export Options
About this article
Cite this article as:
Abadleh M. Mohammed, El-Abadelah M. Mustafa, Sabri S. Salim, Abdallah M.A. Qasem, Nasr Abdelrahman and El-Badawy F. Mohamed, Synthesis and Biological Activity of Some New N1-(6-fluoro-4-oxoquinolin- 8-yl)amidrazones, Letters in Organic Chemistry 2014; 11 (9) . https://dx.doi.org/10.2174/1570178611666140807004701
DOI https://dx.doi.org/10.2174/1570178611666140807004701 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Application of Charge Transfer Reactions for the Quantitative Spectrophotometric Determination of Cyclophosphamide in Pure and Pharmaceutical Formulation
Current Pharmaceutical Analysis The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Application of Proteome Analysis to the Assessment of Prognosis and Response Prediction in Clinical Oncology
Current Cancer Drug Targets Recent Progress in Biomedical Applications of Magnetic Nanoparticles
Recent Patents on Nanotechnology Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Concept of Comprehensive Treatment for Osteoarthritis (OA)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Simultaneous UPLC-MS/MS Determination of 6-mercaptopurine, 6-methylmercaptopurine and 6-thioguanine in Plasma: Application to the Pharmacokinetic Evaluation of Novel Dosage forms in Beagle Dogs
Current Pharmaceutical Design Molecular Imprinting-Based Chemiluminescence Techniques in Pharmaceutical Analysis
Current Pharmaceutical Analysis Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
Current Medicinal Chemistry Future of Protease Activity Assays
Current Pharmaceutical Design Computational Prediction of Ubiquitination Proteins Using Evolutionary Profiles and Functional Domain Annotation
Current Genomics Bioactivity of New μ and δ Opioid Peptides
Medicinal Chemistry Objective Biomarkers or Symptom Scores for the Classification of Fibromyalgia Syndrome?
Current Rheumatology Reviews Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
Current Pharmaceutical Design Determination of Monoaromatic Hydrocarbons in Water Samples by Nano-Liquid Chromatography using a Composite Carbon Nanotubes- Lauryl Polymethacrylate Capillary Monolithic Column
Current Analytical Chemistry 4-Oxothiazolidines with Exocyclic C=C Double Bond(s): Synthesis, Structure, Reactions and Biological Activity
Current Organic Chemistry Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy
Current Pharmacogenomics and Personalized Medicine Diagnosis Model of Paraquat Poisoning Based on Machine Learning
Current Pharmaceutical Analysis Analgesic Considerations for Liver Transplantation Patients
Current Clinical Pharmacology Advances in the Development of Site-Specific Antibody-Drug Conjugation
Anti-Cancer Agents in Medicinal Chemistry